These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24640523)

  • 1. Hypertrophic or non-compaction cardiomyopathy: a challenging diagnosis.
    Cahil A; Penicka M
    Acta Cardiol; 2014 Feb; 69(1):55-7. PubMed ID: 24640523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects.
    Monserrat L; Hermida-Prieto M; Fernandez X; Rodríguez I; Dumont C; Cazón L; Cuesta MG; Gonzalez-Juanatey C; Peteiro J; Alvarez N; Penas-Lado M; Castro-Beiras A
    Eur Heart J; 2007 Aug; 28(16):1953-61. PubMed ID: 17611253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation.
    Frustaci A; De Luca A; Guida V; Biagini T; Mazza T; Gaudio C; Letizia C; Russo MA; Galea N; Chimenti C
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic impact of genetic testing in hypertrophic cardiomyopathy: The story of two families.
    Lorca R; Martín M; Gómez J; Junquera MR; Morís C; Coto E; Reguero JJR
    Int J Cardiol; 2016 Feb; 205():161-162. PubMed ID: 26736093
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of familial hypertrophic cardiomyopathy emphasizes the importance of parallel screening of multiple disease genes.
    Scheffold T; Waldmüller S; Borisov K
    Clin Res Cardiol; 2011 Jul; 100(7):627-8. PubMed ID: 21409595
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiac beta-myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies.
    Hoedemaekers YM; Caliskan K; Majoor-Krakauer D; van de Laar I; Michels M; Witsenburg M; ten Cate FJ; Simoons ML; Dooijes D
    Eur Heart J; 2007 Nov; 28(22):2732-7. PubMed ID: 17947214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extreme septal hypertrophy in an adolescent with congenital familial hypertrophic cardiomyopathy.
    Park BW; Lee MH; Bang DW; Hyon MS
    Korean J Intern Med; 2015 Nov; 30(6):940-1. PubMed ID: 26552475
    [No Abstract]   [Full Text] [Related]  

  • 8. Fatal hypertrophic cardiomyopathy and nemaline myopathy associated with ACTA1 K336E mutation.
    D'Amico A; Graziano C; Pacileo G; Petrini S; Nowak KJ; Boldrini R; Jacques A; Feng JJ; Porfirio B; Sewry CA; Santorelli FM; Limongelli G; Bertini E; Laing N; Marston SB
    Neuromuscul Disord; 2006 Oct; 16(9-10):548-52. PubMed ID: 16945537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations.
    Havndrup O; Bundgaard H; Andersen PS; Allan Larsen L; Vuust J; Kjeldsen K; Christiansen M
    Cardiovasc Res; 2003 Feb; 57(2):347-57. PubMed ID: 12566107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of myocardial dysfunction using three-dimensional speckle tracking echocardiography in a genetic positive hypertrophic cardiomyopathy Chinese family.
    Wang J; Guo RQ; Guo JY; Zuo L; Lei CH; Shao H; Wang LF; Zhang YM; Liu LW
    Cardiol Young; 2018 Sep; 28(9):1106-1114. PubMed ID: 29978770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene.
    Hallıoğlu Kılınç O; Giray D; Bişgin A; Tuğ Bozdoğan S; Karpuz D
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):450-453. PubMed ID: 28694399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypertrophic cardiomyopathy: clinical features, molecular genetics and molecular genetic testing.
    Taylor MR; Carniel E; Mestroni L
    Expert Rev Mol Diagn; 2004 Jan; 4(1):99-113. PubMed ID: 14711353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatically different phenotypic expressions of hypertrophic cardiomyopathy in male cousins undergoing cardiac transplantation with identical disease-causing gene mutation.
    Roberts WC; Roberts CC; Ko JM; Grayburn PA; Tandon A; Kuiper JJ; Capehart JE; Hall SA
    Am J Cardiol; 2013 Jun; 111(12):1818-22. PubMed ID: 23540544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiopathic restrictive cardiomyopathy in children is caused by mutations in cardiac sarcomere protein genes.
    Kaski JP; Syrris P; Burch M; Tomé-Esteban MT; Fenton M; Christiansen M; Andersen PS; Sebire N; Ashworth M; Deanfield JE; McKenna WJ; Elliott PM
    Heart; 2008 Nov; 94(11):1478-84. PubMed ID: 18467357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene.
    Ehlermann P; Weichenhan D; Zehelein J; Steen H; Pribe R; Zeller R; Lehrke S; Zugck C; Ivandic BT; Katus HA
    BMC Med Genet; 2008 Oct; 9():95. PubMed ID: 18957093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
    Maron BJ; Maron MS; Semsarian C
    J Am Coll Cardiol; 2012 Aug; 60(8):705-15. PubMed ID: 22796258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations: prediction of clinical status--is molecular genetics a new tool for the management of hypertrophic cardiomyopathy in clinical practice?
    Hengstenberg C; Erdmann J; Charron P
    Cardiovasc Res; 2003 Feb; 57(2):298-301. PubMed ID: 12566102
    [No Abstract]   [Full Text] [Related]  

  • 19. Familial hypertrophic cardiomyopathy complicated by complete atrioventricular block.
    Cicek D; Camsari A; Doven O
    Acta Cardiol; 2004 Feb; 59(1):71-4. PubMed ID: 15030138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent heterogeneity of familiar hypertrophic cardiomyopathy phenotype: a role of cardiovascular magnetic resonance.
    Glaveckaitė S; Rudys A; Mikštienė V; Valevičienė N; Palionis D; Laucevičius A
    Medicina (Kaunas); 2013; 49(9):422-5. PubMed ID: 24589579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.